GeoVax Labs Inc (GOVX)

NASDAQ HEALTHCARE
$1.05 -4.55% RSI 30 Oversold Add Alert

Moving Averages

SMA 200
$10.35
Price below

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$2.74M
P/E Ratio
None
EPS
$-31.75
Beta
3.805
Dividend Yield
0.00%
52-Week High
$34.75
52-Week Low
$1.137

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 55.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 49.0
MRNA
Moderna Inc
RSI 38.0
VKTX
Viking Therapeutics Inc
RSI 43.0
SRPT
Sarepta Therapeutics Inc
RSI 53.0

Data last updated: April 11, 2026 at 8:02 AM EDT

Track GOVX for free

Get e-mail RSI alerts when GeoVax Labs Inc enters oversold or overbought territory. Free forever.

Add Alert